Are you sure you want to log out?
Background: Preeclampsia is one of the medical diseases of pregnancy and a leading cause of maternal, fetal and perinatal morbidity and mortality. The role of serum uric acid in determining the outcome of pregnancies complicated by preeclampsia has been controversial. Hence if a correlation or association is determined, it may be a veritable asset to the clinicians in preventing the fetomaternal morbidity and mortality associated with the disease. Aim/Objectives: To compare mean serum uric acid levels between severe preeclamptics and normotensive women at term and to ascertain the correlation between serum uric acid levels and outcomes of preeclampsia; as well as determine if there is a threshold value of serum uric acid level beyond which adverse fetomaternal outcomes are expected. Study design: A case-controlled study. Setting: The antenatal clinics, antenatal wards, labour wards and accident and emergency units of Alex Ekwueme Federal University Teaching Hospital Abakaliki and St Patrick’s Mile 4 hospital Abakaliki. Method: This was a case control study where equal numbers of severe pre-eclamptics at term and normotensive women matched for gestational age were recruited. Blood samples were collected from each group for assay of the serum uric acid levels and they were followed up till delivery. The fetomaternal outcomes and the corresponding serum uric acid levels at diagnosis were documented. Variables were studied using statistical tools. Comparisons between categorical variables were done using chi-square/ fishers exact test while comparisons between continuous variables were done using students ttest. Test for association between serum uric acid levels and adverse pregnancy outcomes was done with binary logistic regression. Adjusted odds ratio at 95% confidence interval was calculated for other confounding variables. A Receiver Operating Characteristic (ROC) curve was used to determine the cut-off value of uric acid using the best sensitivity and specificity values beyond which adverse fetomateral complications are likely to occur in pre-eclamptics.